HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease.
Takahashi
Megumi
M
Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Kimura
Akinori
A
D015703:Antigens, CD / Q000235:genetics*; D044466:Asian People / Q000235:genetics; D060908:CTLA-4 Antigen; D004843:Epistasis, Genetic; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006111:Graves Disease / Q000208:ethnology / Q000235:genetics*; D006680:HLA Antigens / Q000235:genetics*; D015234:HLA-A Antigens / Q000235:genetics; D006682:HLA-DP Antigens / Q000235:genetics; D059868:HLA-DP beta-Chains; D006801:Humans; D007564:Japan; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D012307:Risk Factors
D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D006680:HLA Antigens; D015234:HLA-A Antigens; D006682:HLA-DP Antigens; D059868:HLA-DP beta-Chains; C071170:HLA-DPB1 antigen